Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL1094250 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
BCL2 apoptosis regulator/Apoptosis regulator Bcl-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4860] [GtoPdb: 2844] [UniProtKB: P10415] | ||||||||
ChEMBL | Displacement of FITC-labeled Bak BH3 peptide from Bcl-2 after 30 mins by fluorescence polarization assay | B | 5.94 | pIC50 | 1140 | nM | IC50 | J Med Chem (2010) 53: 4166-4176 [PMID:20443627] |
ChEMBL | Displacement of FITC-labeled Bak BH3 peptide from Bcl-2 after 30 mins by fluorescence polarization assay | B | 6.49 | pIC50 | 320 | nM | IC50 | J Med Chem (2010) 53: 4166-4176 [PMID:20443627] |
ChEMBL | Inhibition of BH3 peptide binding to Bcl-2 (unknown origin) | B | 6.49 | pIC50 | 320 | nM | IC50 | Eur J Med Chem (2020) 201: 112446-112446 [PMID:32563811] |
Bcl-2-like 1/Apoptosis regulator Bcl-X in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4625] [GtoPdb: 2845] [UniProtKB: Q07817] | ||||||||
ChEMBL | Binding affinity to Bcl-XL by isothermal titration calorimetric assay | B | 5.62 | pKd | 2400 | nM | Kd | J Med Chem (2010) 53: 4166-4176 [PMID:20443627] |
ChEMBL | Binding affinity to Bcl-XL by isothermal titration calorimetric assay | B | 7 | pKd | 100 | nM | Kd | J Med Chem (2010) 53: 4166-4176 [PMID:20443627] |
ChEMBL | Displacement of FITC-labeled Bak BH3 peptide from Bcl-XL after 30 mins by fluorescence polarization assay | B | 6.17 | pIC50 | 680 | nM | IC50 | J Med Chem (2010) 53: 4166-4176 [PMID:20443627] |
ChEMBL | Displacement of FITC-labeled Bak BH3 peptide from Bcl-XL after 30 mins by fluorescence polarization assay | B | 6.51 | pIC50 | 310 | nM | IC50 | J Med Chem (2010) 53: 4166-4176 [PMID:20443627] |
ChEMBL | Inhibition of BH3 peptide binding to Bcl-xL (unknown origin) | B | 6.51 | pIC50 | 310 | nM | IC50 | Eur J Med Chem (2020) 201: 112446-112446 [PMID:32563811] |
Bcl-2-related protein A1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6044] [UniProtKB: Q16548] | ||||||||
ChEMBL | Displacement of FITC-labeled Bak BH3 peptide from Bfl-1 after 30 mins by fluorescence polarization assay | B | 6.21 | pIC50 | 620 | nM | IC50 | J Med Chem (2010) 53: 4166-4176 [PMID:20443627] |
ChEMBL | Inhibition of BH3 peptide binding to Bfl-1 (unknown origin) | B | 6.21 | pIC50 | 620 | nM | IC50 | Eur J Med Chem (2020) 201: 112446-112446 [PMID:32563811] |
ChEMBL | Displacement of FITC-labeled Bak BH3 peptide from Bfl-1 after 30 mins by fluorescence polarization assay | B | 6.23 | pIC50 | 590 | nM | IC50 | J Med Chem (2010) 53: 4166-4176 [PMID:20443627] |
MCL1 apoptosis regulator, BCL2 family member/Induced myeloid leukemia cell differentiation protein Mcl-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4361] [GtoPdb: 2847] [UniProtKB: Q07820] | ||||||||
ChEMBL | Displacement of FITC-labeled Bak BH3 peptide from Mcl-1 after 30 mins by fluorescence polarization assay | B | 6.7 | pIC50 | 200 | nM | IC50 | J Med Chem (2010) 53: 4166-4176 [PMID:20443627] |
ChEMBL | Inhibition of BH3 peptide binding to Mcl-1 (unknown origin) | B | 6.7 | pIC50 | 200 | nM | IC50 | Eur J Med Chem (2020) 201: 112446-112446 [PMID:32563811] |
ChEMBL | Displacement of FITC-labeled Bak BH3 peptide from Mcl-1 after 30 mins by fluorescence polarization assay | B | 6.74 | pIC50 | 180 | nM | IC50 | J Med Chem (2010) 53: 4166-4176 [PMID:20443627] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]